$ETON News

Eton Pharmaceuticals (ETON) Stock Still Looks Rich Despite Its New Seizure Drug License

HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $70 Price Target

Eton Pharmaceuticals (NASDAQ:ETON): High Growth Momentum Meets a Breakout Setup

Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules

PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M

Jim Cramer Explains Mad Money Caller How to Handle Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference

Insider Unloading: David Krempa Sells Options, Realizes $1.43M

SEAN BRYNJELSEN Executes Sell Order: Offloads $6.09M In Eton Pharmaceuticals Stock

Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript

Is Eton Pharmaceuticals (ETON) Fully Priced On Strong Q2 Results And Raised Guidance?

Why Top 3% Biotech Stock, Eton, Just Catapulted To A Record High

Why Eton Pharmaceuticals Is Top of the Class Today

This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day

Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68

Eton Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary

B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

Eton Pharmaceuticals: No Reason Pharma Can't Deliver More Great Earnings Like These

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

Eton Pharmaceuticals Inc (ETON) (Q2 2026) Earnings Call Highlights: Record Revenue and ...